umifenovir and cobicistat
umifenovir has been researched along with cobicistat in 5 studies
Compound Research Comparison
| Studies (umifenovir) | Trials (umifenovir) | Recent Studies (post-2010) (umifenovir) | Studies (cobicistat) | Trials (cobicistat) | Recent Studies (post-2010) (cobicistat) |
|---|---|---|---|---|---|
| 234 | 23 | 172 | 300 | 75 | 282 |
Protein Interaction Comparison
| Protein | Taxonomy | umifenovir (IC50) | cobicistat (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.15 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 9.2 |
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Duan, Y; Zhou, C; Zhu, HL | 1 |
| Chen, C; Chen, M; Cheng, C; Chi, Y; Hu, Z; Huang, S; Jiao, D; Liang, C; Liu, Y; Lv, Y; Sun, W; Wei, H; Yi, Y; Zhang, X | 1 |
| Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J | 1 |
| Chao, CM; Hsueh, PR; Lai, CC | 1 |
Reviews
1 review(s) available for umifenovir and cobicistat
| Article | Year |
|---|---|
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Carbamates; Cobicistat; COVID-19 Drug Treatment; Darunavir; Dibenzothiepins; Drug Combinations; Drug Therapy, Combination; Humans; Imidazoles; Indoles; Iran; Lopinavir; Morpholines; Pyrazines; Pyridones; Pyrrolidines; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Triazines; Valine | 2021 |
Other Studies
4 other study(ies) available for umifenovir and cobicistat
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
Topics: Adolescent; Adult; Antiviral Agents; Betacoronavirus; China; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Female; Humans; Indoles; Male; Methylprednisolone; Olfaction Disorders; Pandemics; Pneumonia, Viral; SARS-CoV-2; Taste Disorders; Treatment Outcome; Vitamin B 12 | 2020 |
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |